Project: Therapeutic use of epigenetic modulators in oncological and neurodegenerative disease

To develop epigenetic modulators for the treatment of oncological and neurodegenerative disease. We will: -Identify compounds with adequate pharmacological profile targeting novel epigenetic targets -Find the optimal indication for our compounds and strong mechanism of action evidence to support the claims -Find promising synergistic effects with standard of care treatments and optimize the combination therapy -Advance our compounds as rapidly as possible through preclinical and clinical phase

Acronym	EMTherapy (Reference Number: 9683)
Duration	01/10/2015 - 01/06/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 3

Project partner

Number	Name	Role	Country
21311	ORYZON GENOMICS S.A.	Coordinator	Spain
21312	4SC AG	Partner	Germany
21313	INVENTIVA SAS	Partner	France